Western Europe Cancer Hormone Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Western Europe Cancer Hormone Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Western Europe Cancer Hormone Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Western Europe Cancer Hormone Therapy Market Regional Analysis

6.2 Western Europe Cancer Hormone Therapy Market Revenue 2021-2031 (US$ Million)

6.3 Western Europe Cancer Hormone Therapy Market Forecast Analysis

7. Western Europe Cancer Hormone Therapy Market Analysis – by Drug Class

7.1 GnRH Analogs

7.1.1 Overview
7.1.2 GnRH Analogs: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 GnRH Antagonists

7.2.1 Overview
7.2.2 GnRH Antagonists: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Androgen Receptor Antagonists

7.3.1 Overview
7.3.2 Androgen Receptor Antagonists: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Aromatase Inhibitors

7.4.1 Overview
7.4.2 Aromatase Inhibitors: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Selective Estrogen Receptor Modulators

7.5.1 Overview
7.5.2 Selective Estrogen Receptor Modulators: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Estrogen Receptor Antagonists

7.6.1 Overview
7.6.2 Estrogen Receptor Antagonists: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Thyroid Hormone Therapy

7.7.1 Overview
7.7.2 Thyroid Hormone Therapy: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Other Drug Classes

7.8.1 Overview
7.8.2 Other Drug Classes: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Western Europe Cancer Hormone Therapy Market Analysis – by Cancer Type

8.1 Breast Cancer

8.1.1 Overview
8.1.2 Breast Cancer: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Prostate Cancer

8.2.1 Overview
8.2.2 Prostate Cancer: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Endometrial Cancer

8.3.1 Overview
8.3.2 Endometrial Cancer: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Ovarian Cancer

8.4.1 Overview
8.4.2 Ovarian Cancer: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Thyroid Cancer

8.5.1 Overview
8.5.2 Thyroid Cancer: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Other Cancer Types

8.6.1 Overview
8.6.2 Other Cancer Types: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Western Europe Cancer Hormone Therapy Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Implantable

9.3.1 Overview
9.3.2 Implantable: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Western Europe Cancer Hormone Therapy Market Analysis – by Sales Channel

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Cancer Treatment Centers

10.2.1 Overview
10.2.2 Cancer Treatment Centers: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Specialty Clinics

10.3.1 Overview
10.3.2 Specialty Clinics: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.4 Retail Pharmacies

10.4.1 Overview
10.4.2 Retail Pharmacies: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Western Europe Cancer Hormone Therapy Market – Western Europe Analysis

11.1 Overview

11.2 Western Europe

11.2.1 Western Europe Cancer Hormone Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
11.2.1.1 Western Europe Cancer Hormone Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Belgium: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 Belgium: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.1.2 Belgium: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.1.3 Belgium: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.1.4 Belgium: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.2 Netherlands: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Netherlands: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.2.2 Netherlands: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.2.3 Netherlands: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.2.4 Netherlands: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.3 Luxembourg: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Luxembourg: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.3.2 Luxembourg: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.3.3 Luxembourg: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.3.4 Luxembourg: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.4 Germany: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Germany: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.4.2 Germany: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.4.3 Germany: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.4.4 Germany: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.5 France: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 France: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.5.2 France: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.5.3 France: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.5.4 France: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.6 Italy: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Italy: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.6.2 Italy: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.6.3 Italy: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.6.4 Italy: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.7 Spain: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.7.1 Spain: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.7.2 Spain: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.7.3 Spain: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.7.4 Spain: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.8 Switzerland: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.8.1 Switzerland: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.8.2 Switzerland: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.8.3 Switzerland: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.8.4 Switzerland: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.9 Sweden: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.9.1 Sweden: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.9.2 Sweden: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.9.3 Sweden: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.9.4 Sweden: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.10 Austria: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.10.1 Austria: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.10.2 Austria: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.10.3 Austria: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.10.4 Austria: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.11 United Kingdom: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.11.1 United Kingdom: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.11.2 United Kingdom: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.11.3 United Kingdom: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.11.4 United Kingdom: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.12 Denmark: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.12.1 Denmark: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.12.2 Denmark: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.12.3 Denmark: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.12.4 Denmark: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.13 Portugal: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.13.1 Portugal: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.13.2 Portugal: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.13.3 Portugal: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.13.4 Portugal: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.14 Norway: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.14.1 Norway: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.14.2 Norway: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.14.3 Norway: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.14.4 Norway: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

11.2.1.15 Finland: Western Europe Cancer Hormone Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.15.1 Finland: Western Europe Cancer Hormone Therapy Market Breakdown, by Drug Class
11.2.1.15.2 Finland: Western Europe Cancer Hormone Therapy Market Breakdown, by Cancer Type
11.2.1.15.3 Finland: Western Europe Cancer Hormone Therapy Market Breakdown, by Route of Administration
11.2.1.15.4 Finland: Western Europe Cancer Hormone Therapy Market Breakdown, by Sales Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 AbbVie

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Novartis AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 AstraZeneca

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Sanofi

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Eli Lilly and Co

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 F. Hoffmann-La Roche Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Astellas Pharma Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Ipsen Pharma

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Western Europe Cancer Hormone Therapy Market (2021–2031)